Monograph was founded to invest in life sciences companies that seek to create new or improved therapeutics, diagnostics and related technology-enabled business services which enhance healthcare outcomes. With primary offices in London, San Francisco and Dallas-Fort Worth, Monograph bridges opportunities across North America, the United Kingdom and Europe, bringing deep experience, relationships, and capabilities to help these companies scale.
The Monograph team combines decades of experience in biomedical research and clinical medicine with over 55 years of investing experience in the healthcare industry cumulatively across the Monograph Partners. This experience allows Monograph to actively contribute to the growth of nascent organizations into promising biotechnology and related life sciences businesses. Monograph routinely sees opportunities it believes could contribute to transformational healthcare outcomes.
Company Details
- Employees
- 17
- Address
- London, Gb
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://monograph.bio/
- HQ
- London
Monograph Capital Questions
Monograph Capital's website is https://monograph.bio/
Monograph Capital's LinkedIn profile is https://www.linkedin.com/company/monograph-capital
Monograph Capital has
17 employees.
View email and phone details for 17
employees at Monograph Capital.
Monograph Capital's industry is
Venture Capital and Private Equity Principals
Monograph Capital's top competitors are
Solasta Ventures,
Forbion,
Lifearc Ventures,
Patagonia,
Bgf,
Hi-Bio: A Biogen Company,
Ouro Medicines,
Maxion Therapeutics,
Syncona Limited,
Vida Ventures, Llc.
Monograph Capital's categories are Venture Capital and Private Equity Principals
